Advertisement

January 21, 2020

SoundBite Crossing System for Treating Peripheral CTOs Receives FDA Clearance

January 21, 2020—SoundBite Medical Solutions Inc. announced it has received FDA 510(k) clearance for the SoundBite crossing system with active wire technology for use in the treatment of peripheral chronic total occlusions.

According to the company, which is based in Montreal, Quebec, the SoundBite technology is designed to deliver high-amplitude shock wave pulses in a controllable manner through guidewires and other interventional tools to specifically attack highly calcified and fibrotic tissue in the vascular system while leaving healthy, elastic arterial walls unharmed.

Advertisement


January 21, 2020

Ra Medical Gains IDE to Conduct Pivotal Laser Atherectomy Trial of the DABRA System

January 17, 2020

Study Shows More Than Half of United States Clinical Trials Fail to Comply With Law on Reporting Results